ArticleClinical and experimental medicine2024

Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs.

Xinyuan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.